4 Dec 2014
Bryan, aged 79 years has been smoking for about 33 years and has used all forms of tobacco products along the way. He was diagnosed with chronic obstructive pulmonary disease (COPD) in 1998. He has been wrestling his way out since then with pulmonary rehabilitation and medications. His family has been financially affected due to the high cost of treatment. Today, he resents having smoked.
COPD includes an umbrella of lung diseases that obstruct airflow in the lungs. It simply implies that it causes breathing difficulty in a person, the person has air hunger and he needs to strain more to get air into his lungs. This is difficult for any person to go through. The more familiar terms 'Chronic Bronchitis' and 'Emphysema' are no longer used but are included within the diagnosis of COPD.
Like Bryan, millions of people worldwide are affected by COPD. The World Health Organization (WHO) predicts that COPD will become the third leading cause of death worldwide by 2030.
What are the primary risk factors for developing COPD?
What are the symptoms of COPD?
COPD develops slowly over the years and therefore is diagnosed more commonly in people aged over 49 years and with several years of smoking history.
How can one be diagnosed with COPD?
Spirometry is a simple test performed to confirm COPD. The test measures how deeply a person can breathe and how fast air movement occurs within and out of the lungs. A low peak flow measure on spirometry is consistent with COPD.
How to go about being treated or managing COPD?
Over the years, several self-help groups and health management systems have come up with pulmonary rehabilitation as an important management tool for COPD.
The goals of effective COPD management are:
People who have chronic cough and sputum production with a history of exposure to risk factors should be tested for airflow limitation.
Reduce further exposure to risk factors, such as tobacco smoke, to prevent progression of the disease. Smoking cessation is the single most cost-effective way to reduce the risk of developing COPD.
Pharmacotherapy for tobacco dependence is now available worldwide. This should be offered to every patient who is tobacco dependent.
Medication used to manage stable COPD:
The Food and Drug Administration (FDA) has recently approved Olodaterol, a long acting beta agonist for the long-term maintenance treatment of COPD.
Article is related to | |
---|---|
Diseases and Conditions | Copd, Emphysema, Tobacco chewing, Dust allergy, Chronic obstructive airway diseases |
Treatment/Therapy | Oxygen therapy |
Lab Tests | Spirometry |
Medical Topics | Bronchodilator |